(F7) Randomized phase II study with GM-CSF and low-dose ARAC in patients with “high risk” myelodysplastic syndromes : H. Gerhartz∗, R. Marcus, A. Delmer, H. Zwierzina, T. de Witte, A. Jacobs, G. Visani, D. Fiére, P. Sonneveld, B. Labar, A.V. Hoffbrand, P. Fenaux, M. Hayat, A. Thyss, L. Debucher, B. Coiffier, W. Sizoo, R. Willemze, M. Ribeiro, S. Suciu, G. Solbu, A. Stern, R. Zittoun for the EORTC Leukemia Group. Med. Dept. III, Klinikum Groβhadern, Munich Univ., 8000 Munich 70, FRG

• Book ID: 113239457
• Publisher: Elsevier Science
• Year: 1991
• Tongue: English
• Weight: 142 KB
• Volume: 15
• Category: Article
• ISSN: 0145-2126
• DOI: 10.1016/0145-2126(91)90376-5